NLRP3 and lung carcinoma: Simvastatin, a classical anti-hyperlipidemic drug, was reported to induce pyroptosis by activating the NLRP3 inflammasomes caspase-1-IL-18 and IL-1β axes in H1299 and A549 lung cancer cell lines without causing poisonousness tohealthy lung cells (126).